- Home
- ED vs DXCM Comparison
ED vs DXCM Comparison
Compare ED & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ED
- DXCM
- Stock Information
- Founded
- ED 1884
- DXCM 1999
- Country
- ED United States
- DXCM United States
- Employees
- ED N/A
- DXCM N/A
- Industry
- ED Power Generation
- DXCM Medical/Dental Instruments
- Sector
- ED Utilities
- DXCM Health Care
- Exchange
- ED Nasdaq
- DXCM Nasdaq
- Market Cap
- ED 36.1B
- DXCM 34.1B
- IPO Year
- ED N/A
- DXCM 2005
- Fundamental
- Price
- ED $100.60
- DXCM $83.52
- Analyst Decision
- ED Hold
- DXCM Strong Buy
- Analyst Count
- ED 10
- DXCM 20
- Target Price
- ED $104.90
- DXCM $98.50
- AVG Volume (30 Days)
- ED 2.9M
- DXCM 3.8M
- Earning Date
- ED 08-07-2025
- DXCM 07-30-2025
- Dividend Yield
- ED 3.38%
- DXCM N/A
- EPS Growth
- ED 4.34
- DXCM N/A
- EPS
- ED 5.42
- DXCM 1.33
- Revenue
- ED $15,774,000,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- ED $8.61
- DXCM $16.74
- Revenue Next Year
- ED $4.15
- DXCM $15.29
- P/E Ratio
- ED $18.56
- DXCM $62.58
- Revenue Growth
- ED 8.49
- DXCM 9.11
- 52 Week Low
- ED $87.28
- DXCM $57.52
- 52 Week High
- ED $114.87
- DXCM $117.19
- Technical
- Relative Strength Index (RSI)
- ED 47.33
- DXCM 49.26
- Support Level
- ED $97.90
- DXCM $82.73
- Resistance Level
- ED $101.38
- DXCM $85.92
- Average True Range (ATR)
- ED 1.61
- DXCM 2.63
- MACD
- ED 0.28
- DXCM -0.09
- Stochastic Oscillator
- ED 63.55
- DXCM 54.33
About ED Consolidated Edison Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York - including New York City and small parts of New Jersey. The two utilities generate nearly all of Con Ed's earnings following the sale of its clean energy business to RWE in early 2023.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.